Pharmacological management of antifungal agents in pulmonary aspergillosis: an updated review-Reference-Cited by-同舟云学术

Pharmacological management of antifungal agents in pulmonary aspergillosis: an updated review

Published:2021-08-18 Issue:2 Volume:20 Page:179-197
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Echeverria-Esnal Daniel¹²^ORCID,Martín-Ontiyuelo Clara³,Navarrete-Rouco Maria Eugenia¹,Barcelo-Vidal Jaime¹,Conde-Estévez David¹⁴,Carballo Nuria¹,De-Antonio Cuscó Marta¹,Ferrández Olivia¹,Horcajada Juan Pablo²⁴⁵,Grau Santiago¹²⁴

Affiliation:

1. Pharmacy Department, Hospital Del Mar, Parc De Salut Mar, Barcelona, Spain

2. Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital Del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain

3. Pneumology Department, Hospital Del Mar, Parc De Salut Mar, Barcelona, Spain

4. Department Of Pharmacology, Universitat Autònoma De Barcelona, Barcelona, Spain

5. Infectious Diseases Department, Hospital Del Mar, Parc De Salut Mar, Barcelona, Spain

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2021.1962292

Reference167 articles.

1. Novel Antifungal Agents and Their Activity against Aspergillus Species

2. The global impact of Aspergillus infection on COPD

3. The clinical spectrum of pulmonary aspergillosis

4. Chronic Pulmonary Aspergillosis: Notes for a Clinician in a Resource-Limited Setting Where There Is No Mycologist

5. In vitro activity of olorofim (F901318) against clinical isolates of cryptic species of Aspergillus by EUCAST and CLSI methodologies

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approaches for posaconazole therapeutic drug monitoring and their clinical benefits;European Journal of Clinical Pharmacology;2024-09-09

2. In vivo pharmacodynamic characterization of a next-generation polyene, SF001, in the invasive pulmonary aspergillosis mouse model;Antimicrobial Agents and Chemotherapy;2024-03-06

3. Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Pulmonary Aspergillosis: A 2-Year Study of a Multidisciplinary Outpatient Clinic;Journal of Fungi;2024-01-26

4. Targeting Aspergillus allergen oryzin with a chemical probe at atomic precision;Scientific Reports;2023-10-20

5. Identification of the shared gene signatures between pulmonary fibrosis and pulmonary hypertension using bioinformatics analysis;Frontiers in Immunology;2023-09-04